{
  "01258_G02_P013098_S00_N15_R1.raw": {
    "Source Name": [
      "P013098"
    ],
    "Assay Name": [
      "01258_G02_P013098_S00_N15_R1.raw"
    ],
    "Raw Data File": [
      "01258_G02_P013098_S00_N15_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N15"
    ]
  },
  "01267_F06_P013138_S00_N22_R1.raw": {
    "Source Name": [
      "P013138"
    ],
    "Assay Name": [
      "01267_F06_P013138_S00_N22_R1.raw"
    ],
    "Raw Data File": [
      "01267_F06_P013138_S00_N22_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N22"
    ]
  },
  "01253_G02_P013028_S00_N15_R1.raw": {
    "Source Name": [
      "P013028"
    ],
    "Assay Name": [
      "01253_G02_P013028_S00_N15_R1.raw"
    ],
    "Raw Data File": [
      "01253_G02_P013028_S00_N15_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N15"
    ]
  },
  "01262_C02_P013105_S00_N11_R1.raw": {
    "Source Name": [
      "P013105"
    ],
    "Assay Name": [
      "01262_C02_P013105_S00_N11_R1.raw"
    ],
    "Raw Data File": [
      "01262_C02_P013105_S00_N11_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N11"
    ]
  },
  "01266_D05_P013136_S00_N12_R1.raw": {
    "Source Name": [
      "P013136"
    ],
    "Assay Name": [
      "01266_D05_P013136_S00_N12_R1.raw"
    ],
    "Raw Data File": [
      "01266_D05_P013136_S00_N12_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N12"
    ]
  },
  "01245_A04_P012911_S00_N01_R1.raw": {
    "Source Name": [
      "P012911"
    ],
    "Assay Name": [
      "01245_A04_P012911_S00_N01_R1.raw"
    ],
    "Raw Data File": [
      "01245_A04_P012911_S00_N01_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N01"
    ]
  },
  "01337_A06_P013155_S00_N17_R1.raw": {
    "Source Name": [
      "P013155"
    ],
    "Assay Name": [
      "01337_A06_P013155_S00_N17_R1.raw"
    ],
    "Raw Data File": [
      "01337_A06_P013155_S00_N17_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N17"
    ]
  },
  "01334_A03_P013148_S00_N17_R1.raw": {
    "Source Name": [
      "P013148"
    ],
    "Assay Name": [
      "01334_A03_P013148_S00_N17_R1.raw"
    ],
    "Raw Data File": [
      "01334_A03_P013148_S00_N17_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N17"
    ]
  },
  "01338_E07_P013158_S00_N05_R1.raw": {
    "Source Name": [
      "P013158"
    ],
    "Assay Name": [
      "01338_E07_P013158_S00_N05_R1.raw"
    ],
    "Raw Data File": [
      "01338_E07_P013158_S00_N05_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N05"
    ]
  },
  "00108_H03_P012694_S00_N24_R1.raw": {
    "Source Name": [
      "P012694"
    ],
    "Assay Name": [
      "00108_H03_P012694_S00_N24_R1.raw"
    ],
    "Raw Data File": [
      "00108_H03_P012694_S00_N24_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N24"
    ]
  },
  "01331_D03_P013143_S00_N20_R1.raw": {
    "Source Name": [
      "P013143"
    ],
    "Assay Name": [
      "01331_D03_P013143_S00_N20_R1.raw"
    ],
    "Raw Data File": [
      "01331_D03_P013143_S00_N20_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N20"
    ]
  },
  "00108_G02_P012694_S00_N15_R1.raw": {
    "Source Name": [
      "P012694"
    ],
    "Assay Name": [
      "00108_G02_P012694_S00_N15_R1.raw"
    ],
    "Raw Data File": [
      "00108_G02_P012694_S00_N15_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N15"
    ]
  },
  "01253_D03_P013028_S00_N20_R1.raw": {
    "Source Name": [
      "P013028"
    ],
    "Assay Name": [
      "01253_D03_P013028_S00_N20_R1.raw"
    ],
    "Raw Data File": [
      "01253_D03_P013028_S00_N20_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N20"
    ]
  },
  "01236_A01_P012696_S00_N01_R1.raw": {
    "Source Name": [
      "P012696"
    ],
    "Assay Name": [
      "01236_A01_P012696_S00_N01_R1.raw"
    ],
    "Raw Data File": [
      "01236_A01_P012696_S00_N01_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N01"
    ]
  },
  "01338_C03_P013156_S00_N19_R1.raw": {
    "Source Name": [
      "P013156"
    ],
    "Assay Name": [
      "01338_C03_P013156_S00_N19_R1.raw"
    ],
    "Raw Data File": [
      "01338_C03_P013156_S00_N19_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N19"
    ]
  },
  "01253_B01_P013028_S00_N02_R1.raw": {
    "Source Name": [
      "P013028"
    ],
    "Assay Name": [
      "01253_B01_P013028_S00_N02_R1.raw"
    ],
    "Raw Data File": [
      "01253_B01_P013028_S00_N02_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N02"
    ]
  },
  "01260_D06_P013102_S00_N20_R1.raw": {
    "Source Name": [
      "P013102"
    ],
    "Assay Name": [
      "01260_D06_P013102_S00_N20_R1.raw"
    ],
    "Raw Data File": [
      "01260_D06_P013102_S00_N20_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N20"
    ]
  },
  "01236_B03_P012696_S00_N18_R1.raw": {
    "Source Name": [
      "P012696"
    ],
    "Assay Name": [
      "01236_B03_P012696_S00_N18_R1.raw"
    ],
    "Raw Data File": [
      "01236_B03_P012696_S00_N18_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N18"
    ]
  },
  "01337_B04_P013155_S00_N02_R1.raw": {
    "Source Name": [
      "P013155"
    ],
    "Assay Name": [
      "01337_B04_P013155_S00_N02_R1.raw"
    ],
    "Raw Data File": [
      "01337_B04_P013155_S00_N02_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N02"
    ]
  },
  "00107_H03_P012579_S00_N24_R2.raw": {
    "Source Name": [
      "P012579"
    ],
    "Assay Name": [
      "00107_H03_P012579_S00_N24_R2.raw"
    ],
    "Raw Data File": [
      "00107_H03_P012579_S00_N24_R2.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N24"
    ]
  },
  "01245_C06_P012911_S00_N19_R1.raw": {
    "Source Name": [
      "P012911"
    ],
    "Assay Name": [
      "01245_C06_P012911_S00_N19_R1.raw"
    ],
    "Raw Data File": [
      "01245_C06_P012911_S00_N19_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N19"
    ]
  },
  "01336_C03_P013152_S00_N19_R2.raw": {
    "Source Name": [
      "P013152"
    ],
    "Assay Name": [
      "01336_C03_P013152_S00_N19_R2.raw"
    ],
    "Raw Data File": [
      "01336_C03_P013152_S00_N19_R2.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N19"
    ]
  },
  "01250_D05_P012913_S00_N12_R1.raw": {
    "Source Name": [
      "P012913"
    ],
    "Assay Name": [
      "01250_D05_P012913_S00_N12_R1.raw"
    ],
    "Raw Data File": [
      "01250_D05_P012913_S00_N12_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N12"
    ]
  },
  "01264_G02_P013132_S00_N15_R1.raw": {
    "Source Name": [
      "P013132"
    ],
    "Assay Name": [
      "01264_G02_P013132_S00_N15_R1.raw"
    ],
    "Raw Data File": [
      "01264_G02_P013132_S00_N15_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N15"
    ]
  },
  "01261_H06_P013104_S00_N24_R1.raw": {
    "Source Name": [
      "P013104"
    ],
    "Assay Name": [
      "01261_H06_P013104_S00_N24_R1.raw"
    ],
    "Raw Data File": [
      "01261_H06_P013104_S00_N24_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N24"
    ]
  },
  "00108_B01_P012694_S00_N02_R1.raw": {
    "Source Name": [
      "P012694"
    ],
    "Assay Name": [
      "00108_B01_P012694_S00_N02_R1.raw"
    ],
    "Raw Data File": [
      "00108_B01_P012694_S00_N02_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N02"
    ]
  },
  "01268_F05_P013140_S00_N14_R1.raw": {
    "Source Name": [
      "P013140"
    ],
    "Assay Name": [
      "01268_F05_P013140_S00_N14_R1.raw"
    ],
    "Raw Data File": [
      "01268_F05_P013140_S00_N14_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N14"
    ]
  },
  "01330_B02_P013141_S00_N10_R1.raw": {
    "Source Name": [
      "P013141"
    ],
    "Assay Name": [
      "01330_B02_P013141_S00_N10_R1.raw"
    ],
    "Raw Data File": [
      "01330_B02_P013141_S00_N10_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N10"
    ]
  },
  "01332_H04_P013145_S00_N08_R1.raw": {
    "Source Name": [
      "P013145"
    ],
    "Assay Name": [
      "01332_H04_P013145_S00_N08_R1.raw"
    ],
    "Raw Data File": [
      "01332_H04_P013145_S00_N08_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N08"
    ]
  },
  "01333_B06_P013147_S00_N18_R1.raw": {
    "Source Name": [
      "P013147"
    ],
    "Assay Name": [
      "01333_B06_P013147_S00_N18_R1.raw"
    ],
    "Raw Data File": [
      "01333_B06_P013147_S00_N18_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N18"
    ]
  },
  "01335_C06_P013151_S00_N19_R1.raw": {
    "Source Name": [
      "P013151"
    ],
    "Assay Name": [
      "01335_C06_P013151_S00_N19_R1.raw"
    ],
    "Raw Data File": [
      "01335_C06_P013151_S00_N19_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N19"
    ]
  },
  "01236_C05_P012697_S00_N11_R2.raw": {
    "Source Name": [
      "P012697"
    ],
    "Assay Name": [
      "01236_C05_P012697_S00_N11_R2.raw"
    ],
    "Raw Data File": [
      "01236_C05_P012697_S00_N11_R2.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N11"
    ]
  },
  "01267_E03_P013137_S00_N21_R1.raw": {
    "Source Name": [
      "P013137"
    ],
    "Assay Name": [
      "01267_E03_P013137_S00_N21_R1.raw"
    ],
    "Raw Data File": [
      "01267_E03_P013137_S00_N21_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N21"
    ]
  },
  "01214_G01_P012340_S00_N07_R1.raw": {
    "Source Name": [
      "P012340"
    ],
    "Assay Name": [
      "01214_G01_P012340_S00_N07_R1.raw"
    ],
    "Raw Data File": [
      "01214_G01_P012340_S00_N07_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N07"
    ]
  },
  "01244_B03_P012909_S00_N18_R2.raw": {
    "Source Name": [
      "P012909"
    ],
    "Assay Name": [
      "01244_B03_P012909_S00_N18_R2.raw"
    ],
    "Raw Data File": [
      "01244_B03_P012909_S00_N18_R2.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N18"
    ]
  },
  "01259_D02_P013100_S00_N12_R1.raw": {
    "Source Name": [
      "P013100"
    ],
    "Assay Name": [
      "01259_D02_P013100_S00_N12_R1.raw"
    ],
    "Raw Data File": [
      "01259_D02_P013100_S00_N12_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N12"
    ]
  },
  "01481_B02_P015041_S00_N10_R1.raw": {
    "Source Name": [
      "P015041"
    ],
    "Assay Name": [
      "01481_B02_P015041_S00_N10_R1.raw"
    ],
    "Raw Data File": [
      "01481_B02_P015041_S00_N10_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N10"
    ]
  },
  "01251_A02_P013026_S00_N09_R1.raw": {
    "Source Name": [
      "P013026"
    ],
    "Assay Name": [
      "01251_A02_P013026_S00_N09_R1.raw"
    ],
    "Raw Data File": [
      "01251_A02_P013026_S00_N09_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N09"
    ]
  },
  "01262_A09_P013108_S00_N17_R1.raw": {
    "Source Name": [
      "P013108"
    ],
    "Assay Name": [
      "01262_A09_P013108_S00_N17_R1.raw"
    ],
    "Raw Data File": [
      "01262_A09_P013108_S00_N17_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N17"
    ]
  },
  "01231_C03_P012890_S00_N19_R2.raw": {
    "Source Name": [
      "P012890"
    ],
    "Assay Name": [
      "01231_C03_P012890_S00_N19_R2.raw"
    ],
    "Raw Data File": [
      "01231_C03_P012890_S00_N19_R2.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N19"
    ]
  },
  "01262_G07_P013108_S00_N07_R1.raw": {
    "Source Name": [
      "P013108"
    ],
    "Assay Name": [
      "01262_G07_P013108_S00_N07_R1.raw"
    ],
    "Raw Data File": [
      "01262_G07_P013108_S00_N07_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N07"
    ]
  },
  "01336_D06_P013153_S00_N20_R1.raw": {
    "Source Name": [
      "P013153"
    ],
    "Assay Name": [
      "01336_D06_P013153_S00_N20_R1.raw"
    ],
    "Raw Data File": [
      "01336_D06_P013153_S00_N20_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N20"
    ]
  },
  "01252_H05_P013025_S00_N16_R1.raw": {
    "Source Name": [
      "P013025"
    ],
    "Assay Name": [
      "01252_H05_P013025_S00_N16_R1.raw"
    ],
    "Raw Data File": [
      "01252_H05_P013025_S00_N16_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N16"
    ]
  },
  "01254_F03_P013030_S00_N22_R1.raw": {
    "Source Name": [
      "P013030"
    ],
    "Assay Name": [
      "01254_F03_P013030_S00_N22_R1.raw"
    ],
    "Raw Data File": [
      "01254_F03_P013030_S00_N22_R1.raw"
    ],
    "Characteristics[Organism]": [
      "human colorectal cancer cell lines"
    ],
    "Characteristics[MaterialType]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin (Roche)"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "55 mM chloroacetamide"
    ],
    "Characteristics[Label]": [
      "label‐free quantification (LFQ)"
    ],
    "Characteristics[NumberOfSamples]": [
      "65 colorectal cancer (CRC) cell lines"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "biological triplicates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[AcquisitionMethod]": [
      "data‐dependent acquisition"
    ],
    "Comment[Instrument]": [
      "Orbitrap Velos mass spectrometer",
      "Orbitrap Elite mass spectrometer",
      "Eksigent nanoLC‐Ultra 1D+",
      "Dionex Ultimate 3000 HPLC system"
    ],
    "Comment[Separation]": [
      "nanoflow LC‐MS/MS"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nl/min"
    ],
    "Comment[GradientTime]": [
      "from 4 to 32% in 96 min"
    ],
    "Comment[FractionationMethod]": [
      "hydrophilic strong anion exchange (hSAX) chromatography"
    ],
    "Comment[NumberOfFractions]": [
      "24 fractions"
    ],
    "Comment[MS2MassAnalyzer]": [
      "MS1 and MS2 spectra were acquired in the Orbitrap"
    ],
    "Comment[FragmentationMethod]": [
      "higher‐energy collisional dissociation (HCD)"
    ],
    "Comment[PrecursorMassTolerance]": [
      "precursor ion tolerance of 4.5 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "fragment ion tolerance was set to 20 ppm for FTMS"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "maximum of two missed cleavages"
    ],
    "Comment[FractionIdentifier]": [
      "N22"
    ]
  }
}